U.S. Vaccine Program Now Flush With Cash but Short on Key Details

Health
By Benjamin Mueller, Noah Weiland and Carl Zimmer from NYT Health https://ift.tt/1sX39NM
via IFTTT Vaccination and Immunization, Coronavirus (2019-nCoV), Regulation and Deregulation of Industry, Clinical Trials, your-feed-healthcare A $5 billion federal program aims to make better Covid vaccines. But vaccine makers are confused by murky regulatory guidance.

Comments

Popular posts from this blog

U.S. Quietly Drafts Plan to End Program That Saved Millions From AIDS

The Jarring Contradiction at the Heart of Kennedy’s Agenda